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Introduction
Tuberculosis is a global health emergency of staggering proportions. Worldwide, Mycobacterium tuberculosis (MTB) causes about 8 million new infections and two million deaths each year (Bloom and Small, 1998; Dye et al., 1999) . The remarkable success of MTB as a pathogen is closely associated with its ability to persist in humans for extended periods without causing disease. It is estimated that one-third of the world population, or about 1.9 billion people, harbors latent MTB infections (Dye et al., 1999; Enarson and Murray, 1996) , which can last for years or decades (Manabe and Bishai, 2000) . This enormous reservoir of latent disease greatly complicates efforts at tuberculosis control.
Despite significant effort in recent years, progress has been slow in understanding the natural history of latent tuberculosis and reactivation (Parrish et al., 1998) . Important unresolved questions include the metabolic state of bacilli during latency, the role that metabolically dampened MTB may play in lengthening the time necessary for effective chemotherapy, and the nature of the bacterial genetic program and host responses that underlie long-term persistence. The failure of bacteria to increase in numbers during latency, the lack of clinical sequelae and the enhanced resistance of latent TB to chemotherapy argue that the bacilli may be metabolically dormant (Gangadharam, 1995; Gupta and Katoch, 1997; Hu et al., 1998; Michele et al., 1999; Mitchison, 1992; Wayne and Sramek, 1994) . However, there is no direct evidence from the genome (Cole et al., 1998) or the laboratory (McCune et al., 1966; Parrish et al., 1998; Robertson, 1933) that MTB is capable of a truly dormant, spore-like state. In addition, chemotherapy can reduce the rate of reactivation in persons with latent TB (Comstock and Woolpert, 1972; Comstock et al., 1979) , and immunotherapy can protect against reactivation in mice (Lowrie et al., 1999) . It is hard to see how these therapies would have any effect in the complete absence of mycobacterial metabolism.
Oxygen tension is one factor frequently associated with the establishment and maintenance of latent TB (Wayne and Sohaskey, 2001) . In vivo, the number of bacilli in a lesion generally correlates well with the degree of oxygenation (Canetti, 1955) , suggesting that O 2 supply may limit MTB growth during infections. Also, inhibition of MTB growth in vivo is associated with formation of hard, fibrous, hypoxic granulomas (Dannenberg, 1993; Yeager et al., 1996) . Replication of MTB requires oxygen, but bacilli show a remarkable ability to survive for years without oxygen in vitro (Canetti, 1955; Corper and Cohn, 1933) . MTB maintained under anaerobic conditions in vitro lose their acid-fast character (Gillespie et al., 1986) and some human studies (Parrish et al., 1998) have associated latent TB with tubercle bacilli that were no longer acid-fast.
Based on these observations, Wayne has pioneered use of hypoxic culture conditions to generate non-replicating persistent bacilli in vitro as a model for latency (Wayne and Diaz, 1967; Wayne and Sramek, 1994; Wayne and Hayes, 1996) . Variants of this model have been used to identify MTB genes potentially important for development or maintenance of the latent state Imboden and Schoolnik, 1998; Lim et al., 1999; Yuan et al., 1998) . One such gene is acr (also known as hspX, Rv2031), which encodes alpha-crystallin. MTB Acr is a dominant antigen in vivo, recognized by most TB patient sera (Lee et al., 1992; Verbon et al., 1992) . Acr is a member of the small heat shock protein family that forms high MW aggregates and has chaperone activity in vitro (Yuan et al., 1996) . Under hypoxic conditions, Acr expression is dramatically and rapidly increased (Florczyk et al., 2001; Manabe et al., 1999; Sherman et al., 2001; Yuan et al., 1996; Yuan et al., 1998) .
We have exploited the powerful regulation of Acr under reduced O 2 tension to provide insight into the nature of the genetic program by which MTB adapts to potentially hypoxic microenvironments within the host. Previously we described the subset of MTB genes (including acr) that respond rapidly to hypoxia and demonstrated that the MTB protein Rv3133c is required for hypoxic induction of acr (Sherman et al., 2001) . Recently it was demonstrated that long-term hypoxic survival of M. bovis BCG required Rv3133c, which was named DosR for dormancy survival regulator (Boon and Dick, 2002 ). The DosR sequence shows homology to transcription factors of the two-component response regulator class, allowing us to make and test several hypotheses about the behavior of this protein. Here, we define a sequence motif to which DosR binds. Transcriptome analysis of wild-type and DosR-mutant MTB strains indicates that this protein is needed to induce nearly all of the MTB genes that respond powerfully to a hypoxic signal. We show that DosR binds to motif sequences upstream of the acr coding region, and that binding is necessary but not sufficient for hypoxic gene induction. We conclude that Rv3133c/DosR is the primary transcription factor to mediate the genetic response to reduced oxygen tension in MTB.
Results

Microarray analysis defines the DosR regulon
We have previously demonstrated that the initial hypoxic response of MTB involves 47 induced genes and results in growth arrest (Sherman et al., 2001 ). Recently we showed that exposure to low levels of nitric oxide (NO) also produces growth arrest and that the same set of MTB genes is induced by both NO and hypoxia (Voskuil, submitted). Coordinate expression following multiple stimuli suggests that these genes may comprise a regulon under control of a common transcription factor. Our previous work demonstrated that induction of the hypoxic response gene acr depends upon expression of the putative two-component response regulator DosR (Sherman et al., 2001) . To investigate its role in expression of other genes, we targeted DosR for deletion from the mycobacterial chromosome. Using a two-step method and sacB/sucrose counterselection (Parish and Stoker, 2000; Pelicic et al., 1996) , we have generated a strain of H37Rv in which DosR has been replaced by a kanamycin-resistance determinant. This deletion (bp 3499282 to bp 3499933 of the H37Rv genome) extends from 18 bp upstream of the putative translation start site to 17 bp upstream of the putative stop codon. Successful gene replacement was confirmed both by site-specific PCR and by Southern blot (data not shown).
To test the role of DosR in the hypoxic response, we performed whole-genome expression profiling on wild-type H37Rv and mutant H37Rv:∆dosR::kan (∆dosR::kan) under both normoxic (normal oxygen) and hypoxic conditions in vitro. Whole-genome microarray technology provides a robust tool to assess expression of many genes simultaneously (DeRisi et al., 1997) . The MTB microarray has provided a powerful way to monitor genome-wide changes in MTB gene expression in response to the drug isoniazid (Wilson et al., 1999) , to study regulatory mutants (Kaushal et al., 2002; Manganelli et al., 2001; Manganelli et al., 2002; Rodriguez et al., 2002) , and to assess the effects of environmental perturbations (Betts et al., 2002; Fisher et al., 2002; Sherman et al., 2001) . To determine if genes in addition to acr are under control of DosR, MTB strains H37Rv and ∆dosR::kan were maintained for two hours at 0.2% O 2 in N 2 as described previously (Sherman et al., 2001; Yuan et al., 1998) . RNA was isolated, labeled and applied to the array surface. The resulting hybridized array was scanned and fluorescent intensities identified regulated ORFs. Data for all ORFs induced or repressed at least 1.8 fold are available on the Journal's Web site, with highlights of the data described below. Consistent with previous results (Sherman et al., 2001) , incubation of MTB for 2 hr. under hypoxic conditions resulted in induction of numerous genes relative to expression under normoxic conditions (supplementary table 1). However, this response was dramatically muted in the dosR mutant (supplementary table 2). Genes whose induction depends on DosR are listed in Table 1 . Notably, of the 27 genes most powerfully induced by hypoxia (≥5.7 fold), 26 require the presence of DosR. Genetic complementation demonstrated that the effects on hypoxic gene induction are due to mutation of DosR and not some unrelated MTB gene. Introduction of DosR to the dosR mutant restored hypoxic gene induction as measured by Western blot for the Acr protein (data not shown). Also, in the closely related mutant H37Rv:∆3134::kan that does not express dosR (Sherman et al., 2001) or respond genetically to reduced O 2 , complementation with dosR restored hypoxic induction of all DosR-dependent genes (data not shown). We conclude that DosR is a crucial component of the MTB hypoxic response.
A consensus motif upstream of hypoxic response genes
Consistent with its role in gene expression, the DosR protein sequence predicts that it is a transcription factor of the two-component response regulator class (Dasgupta et al., 2000) . To begin testing this prediction, we searched by computer analysis with the motif discovery program YMF (Sinha and Tompa, 2002) for shared sequence motifs upstream of hypoxic response genes. Since transcription units in bacteria are often multi-genic, a single binding site could be responsible for activation of contiguous genes. Our analysis revealed a 20 bp palindromic consensus sequence 5' TTSGGGACTWWAGTCCCSAA 3'(S = C/G; W = A/T; Table 2), a variant of which is upstream of 42/50 (84%) MTB genes that are rapidly induced at least two-fold by hypoxia. Using a scoring matrix whose entries are the log likelihood ratios of each base at each position, we determined the best matches to this motif in the H37Rv genome (supplementary table 4). The top 13 scoring sites are all upstream of genes induced by hypoxia and regulated by DosR (Table 3 ). The genes most powerfully induced by hypoxia are most likely to have this motif upstream: 94% of 16 genes induced at least ten-fold were preceded by this motif (Table 1 ). In addition, powerfully induced genes sometimes had multiple copies in their upstream regions.
DosR binds to DNA upstream of the hypoxic response gene acr
To see if DosR could alter gene expression by binding to the hypoxia motif sites, we assessed the ability of this protein to bind specific DNA sequences by electrophoretic mobility shift assay. We expressed the DosR protein in E. coli from an IPTG-inducible promoter (Fig. 1A , lanes 1-3) and mixed protein extracts with radiolabeled DNA corresponding to the 146 bp upstream of the acr coding sequence (Fig. 1B) . Previously we have shown that this region contains all the information necessary to direct the hypoxic induction of acr (Sherman et al., 2001; Yuan et al., 1998) . A band of retarded mobility, indicating protein bound to the DNA, was evident when acr promoter DNA was mixed with E. coli extracts induced to express DosR (Fig. 1B, lane 2) . In addition, DosR is predicted to be a two-component response regulator of the RO III sub-class (Dasgupta et al., 2000; Parkinson and Kofoid, 1992) . Typical of such proteins, the DosR sequence divides into two domains: a C-terminal half with a helix-turn-helix DNA binding motif, and an N-terminal receiver half predicted to participate in a histidine-to-aspartate phosphorelay (Dasgupta et al., 2000) . To begin testing these predictions, we separately expressed the Nterminal and C-terminal portions of DosR in E. coli (Fig. 1A, lanes 4-7) , and assessed the binding of these portions to the acr promoter by mobility shift assay (Fig. 1B) . As expected, a shift was evident upon incubation with extracts induced to express the C-terminus (amino acids 144 -217, Fig. 1B lane 4) but not the N-terminus (amino acids 1 -134, Fig. 1B lane 3) . All mobility shift assays reported here included a large molar excess of unlabeled poly dI/dC and calf thymus DNA, indicating that binding was specific for the acr promoter. Further, we conclude that the protein binding to the acr promoter is DosR and not some unrelated E. coli protein induced by IPTG since E. coli extracts containing the N-terminus of DosR failed to produce a shift.
To facilitate analysis of the interaction between DosR and the acr promoter, we mapped the acr transcription start site by primer extension. A synthetic oligonucleotide of 16 bases that terminates at bp 7 of the acr coding region was used in extension reactions with RNA from oxygenated (rolling) and hypoxic (static) log-phase cultures of MTB. A single start site was visualized 29 bp upstream of the initiator ATG (Fig. 2) . Reactions with additional aliquots of MTB RNA and a different primer confirmed this result (data not shown), which is four bp downstream of the putative acr transcription start site reported by Coates and colleagues . This discrepancy may be due to differences in technique, as Hu et al. sized their extension products on a heterologous sequencing ladder. All base numberings below are relative to the acr transcription start site defined here.
To localize binding of DosR upstream of acr, we performed additional mobility shift assays with double stranded oligonucleotides corresponding to overlapping regions of the acr promoter. We detected protein binding in two distinct regions, a more distal 33 bp stretch from -111 to -79 and a more proximal 33 bp stretch from -66 to -34 (Fig 3A) . Significantly, these regions each contain a copy of the motif defined above (Fig. 3B, 4A) . To assess the specificity of DosR binding to these regions, we repeated the mobility shift assays after adding a 100-fold molar excess of various unlabeled competitor DNAs.
In each case, binding was abolished by addition of the corresponding unlabeled DNA (Fig. 4B, lanes 3 and 9) . In addition, the unlabeled DNA competed for binding to the other acr promoter region (Fig. 4B , lanes 5 and 11). To test specifically the role of the upstream motifs in DosR binding, we mutated four bases within each motif (-94 to -91 in the distal region and -53 to -50 in the proximal region; underlined in Fig. 4A ). The mutated DNAs were no longer able to compete with the wild-type sequence for binding to DosR (Fig 4B, lanes 4, 6, 10, 12) . Furthermore, when mutated versions of -111 to -79 and -66 to -34 were used in mobility shift assays shifted bands were abolished, indicating that the bases mutated are necessary for DosR binding (data not shown).
DosR binding is required for hypoxic gene induction
These results indicate that DosR binds to two distinct regions of the acr promoter, each of which contains an example of the hypoxia motif. To test the functional significance of this binding, we introduced the mutations described above into the acr upstream sequence and assessed the hypoxic responsiveness of the wild-type and mutant promoters by luciferase reporter gene assay (Sherman et al., 2001; Yuan et al., 1998) (Fig. 4C) . None of the mutations had any discernable effect under normal oxygenation. However, mutating from -94 to -91, which eliminated DosR binding to the distal motif sequence, reduced hypoxic responsiveness roughly by half. Mutating from -53 to -50 to eliminate DosR binding to the proximal region reduced hypoxic responsiveness by nearly six-fold. Introducing both mutations simultaneously virtually abolished the induction, indicating that DosR binding to its motif is necessary for a proper hypoxic response in MTB.
Mutating DosR affects hypoxic gene induction
Based on alignment to known two-component response regulators, Asp-54 of DosR is predicted to be a site of phosphorylation that is essential for gene induction. To test the importance of this amino acid to DosR function, we mutated Asp-54 to Glu. This change should conserve the charge and structure of the protein but block the possibility of phosphorylation. Mutated DosR (Asp54Glu) could still bind to the acr promoter (Fig. 5A) . However, in functional assays the mutated DosR was no longer able to mediate hypoxic induction of a luciferase reporter gene under control of the acr promoter (Fig. 5B) . These results indicate that Asp-54 is essential to DosR activity, possibly because it is a site of phosphorylation.
Discussion
We have shown that DosR of MTB is necessary for induction of a robust genetic response to reduced oxygen tension. Further, we have defined a consensus sequence, a variant of which is upstream of nearly all of the hypoxic response genes. We have shown that the DosR protein binds to this sequence upstream of the acr gene, and that binding is necessary but not sufficient for gene induction. Thus we conclude that DosR is a transcription factor that mediates induction of MTB genes in response to hypoxia. Further, consistent with the sequence-based prediction that DosR belongs to the two-component response regulator family of transcriptional activators we find that the C-terminal 73 amino acids are sufficient for DNA binding and that the aspartate at position 54 is essential for activity. Previously this protein was named DevR, because it is differentially expressed in virulent MTB strain H37Rv compared with avirulent H37Ra (Dasgupta et al., 2000; Mayuri et al., 2002; Saini et al., 2002) . Given the functional data presented elsewhere (Boon and Dick, 2002) and here, we believe that the name DosR is more appropriate.
Presence of an upstream motif sequence defined here strongly correlates with genes induced by hypoxia and regulated by DosR. Further, the number of motif sequences and their degree of fit to the consensus as defined by matrix score roughly predict the extent of hypoxic gene induction. Experiments are underway to determine whether the matrix score predicts strength of DNA binding. It will be interesting to see if a perfect match, which exists nowhere in the H37Rv genome, elicits stronger binding and/or more robust gene induction. Still, the link between motif sequence, regulation by hypoxia and by DosR is not exact. For example, a reasonable match to the motif is present upstream of Rv1976c and Rv1977 (score = 11.7), yet these genes are not induced by hypoxia. Conversely, a few genes (e.g. Rv3129 or Rv3841, see Table 1 ) appear to be regulated by DosR without an obvious upstream match to the consensus. These inconsistencies suggest that aspects of sequence or context may affect DosR-mediated gene expression in ways we have not yet discerned. Also, while nearly all the genes powerfully induced by hypoxia are controlled by DosR, there are numerous modestly induced genes for which DosR does not appear to play a role (supplementary table 1). We are now investigating whether another transcription factor or factors also affects the MTB hypoxic response.
We are interested in the signal transduction pathway by which a drop in oxygen tension results in altered MTB gene expression. For instance, it seems reasonable that some heme protein may play a role in monitoring available O 2 , but the identity of this sensor is unknown. The identity of the kinase that activates DosR is also not yet clear. Directly adjacent to dosR on the MTB chromosome is a putative sensor kinase gene Rv3132c, but disruption of that gene had little effect as measured by accumulation of Acr protein (Sherman et al., 2001 ) and little impact on survival during long-term hypoxic dormancy (Boon and Dick, 2002) . Strong sequence homology between Rv3132c and Rv2027c has been noted previously (Dasgupta et al., 2000; Sherman et al., 2001) . We are currently investigating whether either or both of these proteins participate in the phosphorelay that activates DosR.
Another outstanding question is the role of DosR-mediated gene expression and the hypoxic response during MTB infection of a mammalian host. In vitro, both hypoxia and low levels of NO cause MTB to enter a state of growth arrest (Wayne and Hayes, 1996, Voskuil et al, submitted) . In vivo, MTB may be exposed to hypoxia and NO as granulomas form during a normal host response (Flynn and Chan, 2001; Wayne and Sohaskey, 2001) . It is tempting to speculate that host-induced hypoxia/NO curtail bacterial replication, but the ensuing bacterial response results in long-term persistence rather than clearance. Indeed, we have shown recently that DosR response genes are powerfully induced during MTB infection of mice (Voskuil et al, submitted) . However, despite its attractiveness the link between hypoxia, NO and mycobacterial latency in vivo remains circumstantial and will require further testing. Experiments to define the phenotype of the dosR-deletion mutant under hypoxic conditions in vitro and in vivo are underway.
Experimental Procedures
Mycobacteria and culture conditions H37Rv (ATCC 27294), H37Rv:∆dosR::kan and M. bovis BCG-Montreal (ATCC 35735) were grown to mid-log phase in 7H9 media with 0.05% Tween 80 and ADC supplement (Becton Dickinson) and stored as 1 ml aliquots in 15% glycerol (final concentration) at -80ºC. For individual experiments, bacilli were grown in roller bottles in Middlebrook 7H9 medium (Becton Dickinson) with 0.05% Tween 80 and ADC supplement or on Middlebrook 7H10 plates at 37ºC as described (Sherman et al., 1995) . When needed, kanamycin was used at 30 µg/ml (50 µg/ml for E. coli) and hygromycin at 50 µg/ml (200 µg/ml for E. coli).
Targeted MTB Gene Disruption. Targeted disruptions were performed as described previously (Sherman et al., 2001) . Genomic regions (~900 bp each) flanking dosR were amplified by PCR and cloned into the plasmid pKO so as to flank the kan R determinant. Fidelity of the cloned flanking sequences was confirmed by sequence analysis. Constructs were electroporated into mycobacteria as described (Wards and Collins, 1996) and selected on 7H10 plates with hygromycin. In the first screening step, each colony was tested by PCR with two primer pairs, one specific for integration upstream of the gene of interest and the other specific for integration downstream. Colonies positive at either end by PCR were grown to an OD 600 = ~1.0 and plated onto 7H10 plates containing 10% sucrose. Bacilli that grow on sucrose generally have either mutated copies of sacB or have lost the integrated plasmid. A portion of those in which the plasmid is lost will also lose the gene of interest. Colonies appearing on sucrose plates were picked into media and patched separately onto 7H10 plates with kanamycin and hygromycin. Sucrose-resistant, hygromycin-sensitive, kanamycin-resistant colonies (indicating loss of the integrated plasmid) were screened for loss of the gene of interest by PCR and confirmed by Southern blot.
Microarray analysis
RNA isolation was performed as described (Sherman et al., 2001) . Steps in M. tuberculosis DNA microarray gene expression analysis were performed as described (Ehrt et al., 2002; . A 70-mer oligonucleotide-based microarray (tuberculosis oligonucleotide set [Qiagen]) were used. Labeled cDNA was prepared as follows: 2 µg of total RNA and 4.4 µg of random oligonucleotide hexamers were incubated 2 m at 98°C, cooled on ice, combined with Stratascript RTase buffer, 0.5 mM dA, G, CTP, 0.02 mM dTTP, 1.5 nmol Cy3 or Cy5-dUTP (Amersham), and 1.8 µl Stratascript RTase (Stratagene) in a total volume of 25 µl and incubated 10 m at 25°C and 90 m at 42°C. cDNA was purified by microcon-10 (Amicon) filtration. 10 µl hybridization solution (labeled cDNA, 5 µg tRNA, 2X SSC, 25% formamide, 0.1% SDS) was hybridized at 52°C. Microarray-determined ratios were calculated from 3 biological replicates with 2 microarrays for each biological replicate. Microarrays were scanned using a GenePix 4000A (Axon Instruments). The intensities of the two dyes at each spot were quantified using ScanAlyze (Michael Eisen, http://rana.lbl.gov/EisenSoftware.htm). All gene specific spots on the microarray were used to normalize the intensities of Cy3 and Cy5 from each spot. Additional methods and analysis details are available at the following website: http://schoolniklab.stanford.edu/projects/tb.html.
Computer analysis
Of the genes whose induction by hypoxia requires DosR (Table 1) , 27 have noncoding upstream regions of at least 25 bp. For each of these, 250 bp of upstream sequences was collected. The sequences for Rv1737c and Rv2032 were discarded, as they share approximately 250 bp upstream sequence with Rv1738 and acr, respectively, which are already in this set. The motif discovery program YMF (http://bio.cs.washington.edu/software.html) (Sinha and Tompa, 2002) was applied to the remaining 25 upstream sequences. The four to six motifs with greatest zscores produced for each of the lengths 6, 7, 8, and 9 were aligned, resulting in 19 high scoring YMF motifs (supplementary table 3). All instances of these motifs in the 25 upstream sequences, together with the reverse complements of such instances, were collected and similarly aligned, resulting in 100 aligned motif instances from the upstream regions, each of length 20. These induced the 4×20 log likelihood ratio matrix M (first four columns of Table 2 ), where M rj = log 2 (p rj / q r ) for r ∈ {A,T,G,C} and 1 ≤ j ≤ 20; p rj = (n rj + q r ) / (n+1) is the likelihood of residue r in position j; n rj is the number of occurrences of residue r in position j among the 100 aligned motif instances; n = 100 is the number of aligned motif instances; and q r is the background frequency of residue r in the noncoding portion of MTB (q A = q T = 0.19, q G = q C = 0.31). The log likelihood ratio matrix M was used to score every 20-mer in the noncoding portion of the MTB genome, where the score of
The highest scoring 20-mers are shown in Table 3 . Additional high-scoring 20-mers are shown in supplementary table 4.
Expression of DosR in E. coli
To express DosR in E. coli, a DNA fragment of full-length, N-terminal or C-terminal portions of the DosR ORF was amplified by PCR and cloned into pET-22b(+)(Novagen). The resultant plasmid was introduced to E. coli BL21 (DE3) (Novagen). To induce expression of DosR, cultures grown to OD 600 = 0.6 were treated with 1 mM IPTG at room temperature for 5 hours. To prepare bacterial extracts, cells were harvested and washed with 5X sonication buffer (20 mM Tris·Cl (pH 8.0), 100 mM KCl, 10 mM MgCl 2 , 25% glycerol). After washing, cells were resuspended in the same buffer and disrupted by three 45 sec pulses in a bead-beater (Qbiogene Fast prep FP120). Cell extract was obtained by centrifugation at 14,000 x g at 4°C for 30 min.
Electrophoretic mobility shift assay
To assess protein binding, E. coli extracts (prepared as described above) were used as protein source. Oligonucleotides were used as DNA probes, designed so that when annealed, both ends had 5' "a" extensions that could be labeled with [ 32 P]-dTTP by a Klenow fill-in reaction as described (Winterling et al., 1998) . DNA probes were labeled in a 20 µl reaction mixture containing 2 µg of DNA. Gel mobility shift assay was carried out as described (Dhandayuthapani et al., 1997) with some modifications. Binding of protein to DNA fragments was carried out by incubation at room temperature for 10 min in a 20 µl reaction mixture. The mixture was composed of labeled probe (10,000 cpm), 5-10 µg of protein, 25 mM Tris-HCl (pH 8.0), 0.5 mM EDTA, 20 mM KCl, 6 mM MgCl 2 , 1 mM DTT, 50 ng µl -1 poly (dI/dC), 50 ng µl -1 calf thymus DNA and 5% glycerol. After incubation, the reaction was resolved in a 5% non-denaturing TBE polyacrylamide gel (BioRad).
Primer extension
Primer extension was performed as described (Sambrook et al., 1989) , using a synthetic oligonucleotide, sequence 5'-gaacgggaagggtggt-3', and RNA ( 5 -10 µg/rxn)from oxygenated (rolling) and hypoxic (static) log-phase cultures of MTB, isolated as described (Sherman et al., 2001) .
Luciferase reporter gene assay Assay was performed as described previously (Sherman et al., 2001; Yuan et al., 1998) . Briefly, acr promoter (with described mutations) was amplified by PCR and cloned into the integrating mycobacterial shuttle plasmid pMH66 upstream of the firefly luciferase gene. The resultant construct was electroporated into BCG, where it integrated into the phage L5 attachment site. Luciferase activity was assayed in triplicate for 15 sec by TD-20/20 luminometer (Turner Designs).
Other procedures
Mutated versions of dosR and the acr promoter sequence were generated by mutagenic gene fusion PCR (Yon and Fried, 1989) . Mycobacterial transformations were carried out by electroporation as described previously (Sherman et al., 2001; Wards and Collins, 1996) . E. coli strain DH5α (Invitrogen) was used for routine DNA manipulations.
AI47744 to DRS, AI44826 to GKS, and HG02602-01 to MT), NSF (grant DBI-9974498 to MT) and the Sequella Global Tuberculosis Foundation, of which DRS is a Core Scientist. Underlined bases were mutated as follows: "ccaa" "ggtt," and "tcgg" "agcc." B. EMSA with radiolabeled probes and specific unlabeled competitor DNAs. Lanes 1-6, labeled probe (-111 to -79); lanes 7-12, labeled probe (-66 to -34) . Lanes 1 and 7: no extract control. Lanes 2 and 8: no competitor control. Lanes 3 and 11: unlabeled competitor (-111 to -79). Lanes 4 and 12: unlabeled competitor (mutant -111 to -79). Lanes 5 and 9: unlabeled competitor (-66 to -34). Lanes 6 and 10: unlabeled competitor (mutant -66 to -34). C. Hypoxic induction of acr promoter with mutations in the hypoxia motifs. Activity of acr promoter was measured by luciferase reporter gene assay. Indicated mutations in distal and proximal motifs were made as described above. Shown are representative data from one of two experiments, each of which was performed in duplicate. 
